John Peloza
Orthopaedic Surgery of the Spine Chesterfield, MO Medical Doctor
NPI 1245283548 CMS profile 146721
14825 N. Outer 40 Rd, Suite 310, Chesterfield, MO 63017
General payments
$248,639
Research payments
$245
Ownership & investment interest
$568,903
Through program year 2025, John Peloza of Chesterfield, MO is reported in the CMS Open Payments database as having received $248,639 across 218 general payments and $245 in research payments paid to them. They also declared ownership or investment interests valued at $568,903 across 7 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 85th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
15 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $10,554 | 19 | |
| 2024 | General | $1,559 | 9 | |
| 2023 | General | $16,689 | 20 | |
| 2023 | Research | $245 | 1 | |
| 2022 | General | $15,268 | 30 | |
| 2021 | General | $90,224 | 45 | |
| 2020 | General | $44,249 | 28 | |
| 2019 | General | $70,095 | 67 | |
| 2025 | Ownership | $94,725 | 1 | |
| 2024 | Ownership | $92,752 | 1 | |
| 2023 | Ownership | $81,833 | 1 | |
| 2022 | Ownership | $79,060 | 1 | |
| 2021 | Ownership | $76,287 | 1 | |
| 2020 | Ownership | $73,514 | 1 | |
| 2019 | Ownership | $70,733 | 1 |
Beside peers
- John Peloza
- Orthopaedic Surgery of the Spine median
- Middle half of Orthopaedic Surgery of the Spine
- National median
In program year 2025, general payments to John Peloza were reported at $10,554. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.
Show as a table
| Year | John Peloza | Orthopaedic Surgery of the Spine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $70,095 | $2,106 | $337–$18,608 | $163 |
| 2020 | $44,249 | $1,213 | $156–$15,082 | $114 |
| 2021 | $90,224 | $1,834 | $271–$15,617 | $132 |
| 2022 | $15,268 | $2,015 | $320–$17,036 | $149 |
| 2023 | $16,689 | $1,925 | $336–$14,599 | $160 |
| 2024 | $1,559 | $2,110 | $341–$12,483 | $164 |
| 2025 | $10,554 | $2,061 | $347–$14,651 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
219 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Orthopaedic Surgery of the Spine in Missouri
Roger Jackson
Orthopaedic Surgery of the Spine · North Kansas City, MO
Munish Gupta
Orthopaedic Surgery of the Spine · Saint Louis, MO
Jacob Buchowski
Orthopaedic Surgery of the Spine · Saint Louis, MO
Steven Meyer
Orthopaedic Surgery of the Spine · Columbia, MO
Rahul Basho
Orthopaedic Surgery of the Spine · Hannibal, MO
Brian Neuman
Orthopaedic Surgery of the Spine · Saint Louis, MO
Related records
Orthopaedic Surgery of the Spine in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Orthopaedic Surgery of the Spine
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.